Biochemical Science Division, National Institute of Standards and Technology, 100 Bureau Drive, Gaithersburg, Maryland 20899, USA.
Langmuir. 2010 Jun 1;26(11):8559-66. doi: 10.1021/la904616s.
Niosomes are synthetic membrane vesicles formed by self-assembly of nonionic surfactant, often in a mixture with cholesterol and dicetyl phosphate. Because of their inner aqueous core and bilayer membrane shell, niosomes are commonly used as carriers of treatment agents for pharmaceutical and cosmetic applications or contrast agents for clinical imaging applications. In those applications, niosomes are considered as a more economical and stable alternative to their biological counterpart (i.e., liposomes). However, conventional bulk method of niosome preparation requires bulk mixing of two liquid phases, which is time-consuming and not well-controlled. Such mixing conditions often lead to large niosomes with high polydispersity in size and thus affect the consistency of niosome dosage or imaging quality. In this study, we present a new method of niosome self-assembly by microfluidic hydrodynamic focusing to improve on the size and size distributions of niosomes. By taking advantage of the rapid and controlled mixing of two miscible fluids (i.e., alcohol and water) in microchannels, we were able to obtain in seconds nanoscaled niosomes with approximately 40% narrower size distributions compared to the bulk method. We further investigated different parameters that might affect on-chip assembly of niosomes, such as (1) conditions for the microfluidic mixing, (2) chemical structures of the surfactant used (i.e., sorbitan esters Span 20, Span 60, and Span 80), and (3) device materials for the microchannel fabrication. This work suggests that microfluidics may facilitate the development and optimization of biomimetic colloidal systems for nanomedicine applications.
胶束是由非离子表面活性剂自组装形成的合成膜泡,通常与胆固醇和二乙酰基焦磷酸混合。由于其内部水核和双层膜壳,胶束通常被用作药物和化妆品应用的治疗剂载体或临床成像应用的对比剂。在这些应用中,胶束被认为是更经济和稳定的替代物,与它们的生物对应物(即脂质体)相比。然而,传统的胶束制备 bulk 方法需要两相的大量混合,这既耗时又难以控制。这种混合条件通常会导致大的胶束,尺寸的多分散性高,从而影响胶束剂量的一致性或成像质量。在这项研究中,我们提出了一种通过微流体力学聚焦自组装胶束的新方法,以改善胶束的尺寸和尺寸分布。通过利用微通道中两种可混溶流体(即酒精和水)的快速和受控混合,我们能够在几秒钟内获得纳米级胶束,与 bulk 方法相比,其尺寸分布大约窄 40%。我们进一步研究了可能影响胶束在片上组装的不同参数,例如(1)微流混合的条件,(2)所用表面活性剂的化学结构(即山梨糖醇酯 Span 20、Span 60 和 Span 80),以及(3)微通道制造的器件材料。这项工作表明,微流可能有助于仿生胶体系统的开发和优化,用于纳米医学应用。